Es gab 50 kürzliche Insider-Transaktionen für Catalyst Pharmaceuticals, Inc. (CPRX), darunter 19 Käufe und 29 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $21.97M und die gesamten Insider-Verkäufe auf $15.41M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Russo Gregg, Daly Richard J, Kalb Michael Wayne. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CPRX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-17 |
Russo Gregg |
Chief HR Officer |
RSU-Steuereinbehalt |
211 |
- |
- |
476 |
| 2026-01-05 |
Daly Richard J |
President and CEO |
RSU-Steuereinbehalt |
10,577 |
- |
- |
271,266 |
| 2026-01-05 |
Kalb Michael Wayne |
Executive Vice President & CFO |
RSU-Steuereinbehalt |
2,080 |
- |
- |
13,665 |
| 2025-12-29 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Optionsausübung (Verkauf) |
26,334 |
- |
- |
1,851,948 |
| 2025-12-29 |
Denkhaus Donald A |
Director |
Optionsausübung (Verkauf) |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Tierney David S |
Director |
Optionsausübung (Verkauf) |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Miller Steve |
Chief Op. & Scientific Officer |
Optionsausübung |
14,000 |
- |
- |
1,093,803 |
| 2025-12-29 |
Daly Richard J |
President and CEO |
RSU-Steuereinbehalt |
524 |
- |
- |
239,738 |
| 2025-12-29 |
Elsbernd Brian |
Chief Compliance/legal Officer |
RSU-Steuereinbehalt |
2,623 |
- |
- |
242,501 |
| 2025-12-29 |
Del Carmen Jeffrey |
Chief Commercial Officer |
RSU-Steuereinbehalt |
3,839 |
- |
- |
14,337 |
| 2025-12-29 |
Harper Molly |
Director |
Optionsausübung |
1,334 |
- |
- |
3,694 |
| 2025-12-29 |
Sundaram Preethi |
Chief Strategy Officer |
RSU-Steuereinbehalt |
2,369 |
- |
- |
54,804 |
| 2025-12-12 |
Harper Molly |
Director |
Informierter Verkauf |
6,746 |
$23.06 |
$155.56K |
2,360 |
| 2025-12-08 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Optionsausübung (Verkauf) |
3,534 |
- |
- |
1,878,282 |
| 2025-12-08 |
Denkhaus Donald A |
Director |
Optionsausübung (Verkauf) |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Tierney David S |
Director |
Optionsausübung (Verkauf) |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Miller Steve |
Chief Op. & Scientific Officer |
Optionsausübung |
11,873 |
- |
- |
1,079,803 |
| 2025-12-08 |
Elsbernd Brian |
Chief Compliance/legal Officer |
RSU-Steuereinbehalt |
2,780 |
- |
- |
238,457 |
| 2025-12-08 |
Del Carmen Jeffrey |
Chief Commercial Officer |
RSU-Steuereinbehalt |
2,492 |
- |
- |
9,509 |
| 2025-12-08 |
Thompson Tamar |
Director |
Optionsausübung |
1,413 |
- |
- |
3,773 |
| 2025-12-08 |
Harper Molly |
Director |
Optionsausübung |
1,413 |
- |
- |
9,106 |
| 2025-12-08 |
Sundaram Preethi |
Chief Strategy Officer |
RSU-Steuereinbehalt |
1,669 |
- |
- |
50,506 |
| 2025-12-01 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Schenkung (gegeben) |
45,000 |
- |
- |
4,148,477 |
| 2025-11-26 |
Del Carmen Jeffrey |
Chief Commercial Officer |
Informierter Verkauf |
10,983 |
$23.33 |
$256.24K |
3,962 |
| 2025-11-21 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Optionsausübung (Verkauf) |
1,775 |
- |
- |
1,881,816 |
| 2025-11-21 |
Tierney David S |
Director |
Optionsausübung (Verkauf) |
947 |
- |
- |
180,910 |
| 2025-11-21 |
Miller Steve |
Chief Op. & Scientific Officer |
Optionsausübung |
8,267 |
- |
- |
1,067,930 |
| 2025-11-21 |
Daly Richard J |
President and CEO |
Optionsausübung |
20,006 |
- |
- |
246,800 |
| 2025-11-21 |
Kalb Michael Wayne |
Executive Vice President & CFO |
RSU-Steuereinbehalt |
2,485 |
- |
- |
8,606 |
| 2025-11-21 |
Thompson Tamar |
Director |
Optionsausübung |
947 |
- |
- |
2,360 |
| 2025-11-21 |
Harper Molly |
Director |
Optionsausübung |
947 |
- |
- |
7,693 |
| 2025-11-21 |
Sundaram Preethi |
Chief Strategy Officer |
RSU-Steuereinbehalt |
1,364 |
- |
- |
45,320 |
| 2025-11-20 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
RSU-Zuteilung |
34,921 |
$22.77 |
$795.15K |
1,873,051 |
| 2025-11-20 |
Tierney David S |
Director |
RSU-Zuteilung |
18,115 |
$22.77 |
$412.48K |
176,389 |
| 2025-11-20 |
Miller Steve |
Chief Op. & Scientific Officer |
RSU-Zuteilung |
158,454 |
$22.77 |
$3.61M |
1,457,963 |
| 2025-11-20 |
Daly Richard J |
President and CEO |
RSU-Zuteilung |
381,948 |
$22.77 |
$8.7M |
2,546,695 |
| 2025-11-20 |
Kalb Michael Wayne |
Executive Vice President & CFO |
RSU-Zuteilung |
131,536 |
$22.77 |
$3M |
607,235 |
| 2025-11-20 |
Thompson Tamar |
Director |
RSU-Zuteilung |
18,115 |
$22.77 |
$412.48K |
116,555 |
| 2025-11-20 |
Harper Molly |
Director |
RSU-Zuteilung |
18,115 |
$22.77 |
$412.48K |
145,389 |
| 2025-11-20 |
Sundaram Preethi |
Chief Strategy Officer |
RSU-Zuteilung |
106,873 |
$22.77 |
$2.43M |
785,305 |
| 2025-11-20 |
Russo Gregg |
Chief HR Officer |
RSU-Zuteilung |
20,531 |
$22.77 |
$467.49K |
66,276 |
| 2025-06-11 |
Sundaram Preethi |
Chief Strategy Officer |
Informierter Verkauf |
1,600 |
$26.42 |
$42.27K |
41,081 |
| 2025-06-10 |
Sundaram Preethi |
Chief Strategy Officer |
Informierter Verkauf |
2,324 |
$26.41 |
$61.38K |
42,681 |
| 2025-06-09 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Informierter Verkauf |
171,748 |
$26.11 |
$4.48M |
4,281,702 |
| 2025-06-06 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Informierter Verkauf |
28,252 |
$25.95 |
$733K |
4,453,450 |
| 2025-06-02 |
Andrews William T. |
Chief Medical Officer |
Unbekannt |
15,261 |
- |
- |
- |
| 2025-05-30 |
Daly Richard J |
President and CEO |
Informierter Kauf |
70,000 |
$24.86 |
$1.74M |
199,764 |
| 2025-05-14 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Informierter Verkauf |
44,000 |
$23.63 |
$1.04M |
68,873 |
| 2025-05-13 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Informierter Verkauf |
200,000 |
$23.68 |
$4.74M |
68,873 |
| 2025-03-06 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Informierter Verkauf |
180,096 |
$21.67 |
$3.9M |
68,873 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
